3 Things You Should Know About Advances in CLL Management.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 164
- By:
- Publication type:
- Article
Works matching IS 0890-9091 AND VI 39 AND IP 4 AND DT 2025
Results: 8
1
2
3 Things You Should Know About the Multimodal Treatment of SCLC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 160
- By:
- Publication type:
- Article
3
A World of Research, Care, and Science: Becoming a Radiation Oncologist.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 158
- By:
- Publication type:
- Article
4
Rare Primary ALK-Positive Anaplastic Large Cell Lymphoma of the Central Nervous System.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 154
- By:
- Publication type:
- Article
5
Synovial Fluid in Checkpoint Inhibitor-Induced Inflammatory Arthritis.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 148
- By:
- Publication type:
- Article
6
Utility of the Diagnosis-Specific Graded Prognostic Assessment for Prognostication in Leptomeningeal Disease.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 141
- By:
- Publication type:
- Article
7
Durvalumab Does Not Surpass Cetuximab in Head and Neck Cancer, Data Show.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 139
- By:
- Publication type:
- Article
8
Recent ADC Approvals and Their Impact on the Breast Cancer Space.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 4, p. 138
- By:
- Publication type:
- Article